Vertaling van "for the belgian breast cancer " (Frans → Nederlands) :

Application Presentation: Symposium A web-based Support System for the belgian Breast Cancer Screening Program (.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)
Application Presentation: A web-based Support System for the belgian Breast Cancer Screening Program(.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)

(BGES), Belgian Group of Digestive Oncology (BGDO), Belgian Professional Surgical Association, Belgian Section for Colorectal Surgery, a section of the Royal Belgian Society for Surgery (RBSS) Belgian Society of Gastrointestinal Endoscopy (BSGIE), Belgian Society for Pathology (BSP) and Digestive Pathology Club, Belgian Society for Radiotherapy-Oncology (BVRO/ABRO), Belgian Society of Medical Oncology (BSMO), Belgian Society of Surgical Oncology (BSSO), Royal Belgian Society of Radiology, le Collège d’oncologie, l’INAMI, la Société Royale Belge de Gastro-Entérologie, la Fondation registre du cancer et la Vlaamse Vereniging voor Gastro-Enterologie.
Belgian Group of Digestive Oncology (BGDO), Belgian Professional Surgical Association, Belgian Section for Colorectal Surgery, a section of the Royal Belgian Society for Surgery (RBSS) Belgian Society of Gastrointestinal Endoscopy (BSGIE), Belgian Society for Pathology (BSP) and Digestive Pathology Club, Belgian Society for Radiotherapy-Oncology (BVRO/ABRO), Belgian Society of Medical Oncology (BSMO), Belgian Society of Surgical Oncology (BSSO), Royal Belgian Society of Radiology, College voor Oncologie, het RIZIV, Société Royale Belge de Gastro-Entérologie, Stichting Kankerregister en de Vlaamse Vereniging voor Gastro-Enterologie.

Stakeholders : Matteo Cappello (ULB), Paul De Leyn (UZ Leuven), Lore Decoster (Belgian Society for Medical Oncology), Ingel Demedts (Belgische Vereniging voor Pneumologie), Christophe Deroose (Société Belge de Médecine Nucléaire), Dirk De Ruysscher (Belgische Vereniging van Radiotherapie en Oncologie), Roland Hustinx (Société Belge de Médecine Nucléaire), Bart Ilsen (UZ Brussel), Thierry Pieters (Société Belge de Pneumologie), Myriam Remmelink (Belgian Society of Pathology), Vincent Remouchamps (Collège des Médecins en Radiothérapie), Karin Rondia (Fondation Contre le Cancer), Elizabeth Van Eycken (Stichting Kankerregister), Erik Verbeken (Belgian Society of Pathology), Johny Verschakelen (Royal Belgian Society of Radiology).
Matteo Cappello (ULB), Paul De Leyn (UZ Leuven), Lore Decoster (Belgian Society for Medical Oncology), Ingel Demedts (Belgische Vereniging voor Pneumologie), Christophe Deroose (Société Belge de Médecine Nucléaire), Dirk De Ruysscher (Belgische Vereniging van Radiotherapie en Onocologie), Roland Hustinx (Société Belge de Médecine Nucléaire), Bart Ilsen (UZ Brussel), Thierry Pieters (Société Belge de Pneumologie), Myriam Remmelink (Belgian Society of Pathology), Vincent Remouchamps (Collège des Médecins en Radiothérapie), Karin Rondia (Fondation Contre le Cancer), Elisabeth Van Eycken (Stichting Kankerregister), Erik Verbeken (Belgian Society of Pathology), Johny Verschakelen (Royal Belgian Society of Radiology). Harry Groen (University Medical Center Groningen), Johan Vansteenkiste (UZ Leuven - Gasthuisberg), Bert Aertgeerts (KU Leuven, CEBAM)

Table 5: Update of evidence found in SR and HTA Search Radiation harms of mammography screening (40-49 y) questions Note Update of HTA (ETMIS) Date 03/05/2010 Keywords Breast neoplasms, mammography/ adverse effects, mass screening/ adverse effects Medline Case report.tw (156081) (OVID): 2 Letter.pt (689184) Filter 3 Historical article.pt (263481) RCT 4 Review of reported cases.pt (0) 5 Review,multicase.pt (0) 6 or/1-5 (1099551) 7 Breast/ or Breast Diseases/ (30731) 8 Neoplasms/ (216844) 9 7 and 8 (536) 10 exp Breast Neoplasms/ (171800) 11 (breast$ adj5 neoplas$).tw (2557) 12 (breast$ adj5 cancer$).tw (135752) 13 (breast$ adj5 carcin$).tw (31777) 14 (breast$ adj5 tumo$).tw (23441) 15 (breast$ adj5 metasta$).tw (16582) 16 (breast$ adj5 malig$).tw (7361) 17 exp Carcinoma, Ductal, Breast/ (8472) 18 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 (207367) 19 Mammography/ae [Adverse Effects] (517) 20 Mass Screening/ae [Adverse Effects] (325) 21 19 or 20 (763) 22 18 and 21 (443) 23 22 not 6 (379) 24 limit 23 to (yr=" 2005 -Current" and " all adult (19 plus years)" and (dutch or english or french)) (44) 25 from 24 keep 1-44 (44)
Table 3: Update of evidence found in SR and HTA Search Radiation harms of mammography screening (40-49 y) questions Note Update of HTA (ETMIS) Date 03/05/2010 Keywords Breast neoplasms, mammography/ adverse effects, mass screening/ adverse effects Medline Case report.tw (156081) (OVID): 2 Letter.pt (689184) Filter 3 Historical article.pt (263481) RCT 4 Review of reported cases.pt (0) 5 Review,multicase.pt (0) 6 or/1-5 (1099551) 7 Breast/ or Breast Diseases/ (30731) 8 Neoplasms/ (216844) 9 7 and 8 (536) 10 exp Breast Neoplasms/ (171800) 11 (breast$ adj5 neoplas$).tw (2557) 12 (breast$ adj5 cancer$).tw (135752) 13 (breast$ adj5 carcin$).tw (31777) 14 (breast$ adj5 tumo$).tw (23441) 15 (breast$ adj5 metasta$).tw (16582) 16 (breast$ adj5 malig$).tw (7361) 17 exp Carcinoma, Ductal, Breast/ (8472) 18 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 (207367) 19 Mammography/ae [Adverse Effects] (517) 20 Mass Screening/ae [Adverse Effects] (325) 21 19 or 20 (763) 22 18 and 21 (443) 23 22 not 6 (379) 24 limit 23 to (yr=" 2005 -Current" and " all adult (19 plus years)" and (dutch or english or french)) (44) 25 from 24 keep 1-44 (44)

Table 4: Search for additional RCTs Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for RCT’s Date 27/04/2010 Keywords Breast neoplasms (MESH), mass screening (or early detection) (MESH), mammography (MESH) Medline 1 Randomized controlled trials/ (66083) Medline (OVID): (OVID): 2 Randomized controlled trial.pt (289038) Filter Filter 3 Random allocation/ (67885) RCT RCT 4 Double blind method/ (105956) 5 Single blind method/ (13834) 6 Clinical trial.pt (460563) 7 exp clinical trial/ (606505) 8 or/1-7 (718664) 9 (clinic$ adj trial$).tw (146686) 10 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw (105209) 11 Placebos/ (28712) 12 Placebo$.tw (125428) 13 Randomly allocated.tw (12231) 14 (allocated adj2 random).tw (654) 15 9 or 10 or 11 or 12 or 13 or 14 (312732) 16 8 or 15 (842155) 17 Case report.tw (155883) 18 Letter.pt (688664) 19 Historical article.pt (263287) 20 Review of reported cases.pt (0) 21 Review,multicase.pt (0) 22 17 or 18 or 19 or 20 or 21 (1098644) 23 16 not 22 (822810) 24 Breast/ or Breast Diseases/ (30717) 25 Neoplasms/ (216644) 26 24 and 25 (535) 27 (breast$ adj5 neoplasm$).tw (1588) 28 (breast$ adj5 cancer$).tw (135654) 29 (breast$ adj5 carcin$).tw (31778) 30 (breast$ adj5 tumo$).tw (23438) 31 (breast$ adj5 metasta$).tw (16580) 32 (breast$ adj5 malig$).tw (7361) 33 exp Breast Neoplasms/ (171606) 34 exp Carcinoma, Ductal, Breast/ (8460) 35 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (207174) 36 mammography.mp (23598) 37 screening.mp (274211) 38 36 or 37 (288429) 39 23 and 35 and 38 (2326) 40 limit 39 to (yr=" 2008 -Current" and " all adult (19 plus years)" and (dutch or english or french)) (241) 41 from 40 keep 1-241 (241) 42 from 41 keep 1-241 (241) CENTRAL Breast neoplasms (MESH) and early detection (MESH) or 61 mammography (MESH) (manual limit 2008-2010) in title , abstracts or key words
Table 2: Search for additional RCTs Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for RCT’s Date 27/04/2010 Keywords Breast neoplasms (MESH), mass screening (or early detection) (MESH), mammography (MESH) Medline 1 Randomized controlled trials/ (66083) Medline (OVID): (OVID): 2 Randomized controlled trial.pt (289038) Filter Filter 3 Random allocation/ (67885) RCT RCT 4 Double blind method/ (105956) 5 Single blind method/ (13834) 6 Clinical trial.pt (460563) 7 exp clinical trial/ (606505) 8 or/1-7 (718664) 9 (clinic$ adj trial$).tw (146686) 10 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw (105209) 11 Placebos/ (28712) 12 Placebo$.tw (125428) 13 Randomly allocated.tw (12231) 14 (allocated adj2 random).tw (654) 15 9 or 10 or 11 or 12 or 13 or 14 (312732) 16 8 or 15 (842155) 17 Case report.tw (155883) 18 Letter.pt (688664) 19 Historical article.pt (263287) 20 Review of reported cases.pt (0) 21 Review,multicase.pt (0) 22 17 or 18 or 19 or 20 or 21 (1098644) 23 16 not 22 (822810) 24 Breast/ or Breast Diseases/ (30717) 25 Neoplasms/ (216644) 26 24 and 25 (535) 27 (breast$ adj5 neoplasm$).tw (1588) 28 (breast$ adj5 cancer$).tw (135654) 29 (breast$ adj5 carcin$).tw (31778) 30 (breast$ adj5 tumo$).tw (23438) 31 (breast$ adj5 metasta$).tw (16580) 32 (breast$ adj5 malig$).tw (7361) 33 exp Breast Neoplasms/ (171606) 34 exp Carcinoma, Ductal, Breast/ (8460) 35 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (207174) 36 mammography.mp (23598) 37 screening.mp (274211) 38 36 or 37 (288429) 39 23 and 35 and 38 (2326) 40 limit 39 to (yr=" 2008 -Current" and " all adult (19 plus years)" and (dutch or english or french)) (241) 41 from 40 keep 1-241 (241) 42 from 41 keep 1-241 (241) CENTRAL Breast neoplasms (MESH) and early detection (MESH) or 61 mammography (MESH) (manual limit 2008-2010) in title , abstracts or key words

Selon la Fondation Registre du Cancer (Belgian Cancer Registry - BCR) 2 , 1 992 nouveaux cas de cancer de la thyroïde ont été enregistrés en Belgique entre 2004 et 2006, ce qui correspond à un taux d'incidence global de 5,8 par 100 000 personnes-années, soit un taux intermédiaire comparativement aux autres pays européens (< 2 pour la Serbie à > 10 par 100 000 personnes-années pour la France).
Volgens de Stichting Kankerregister (Belgian Cancer Registry - BCR) 2 , werden in de periode 2004-2006 in België 1 992 nieuwe gevallen van schildklierkanker geregistreerd. Dat komt neer op een globale incidentie van 5,8 per 100 000 personen-jaren (PJ), wat in vergelijking met andere Europese landen als een middelmatige incidentie kan worden beschouwd (< 2 voor Servië tot > 10 per 100 000 PJ in Frankrijk).

Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. KCE Reports 185C (D/2012/10.273/61) Available from: [http ...]
Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. KCE Reports 185C (D/2012/10.273/61) Available from: [http ...]

- BCR (Belgian Cancer Registry) validation requested: tous les chapitres ont été remplis et le responsable de la fiche d’enregistrement (responsible specialist) demande une validation à la Fondation registre du cancer.
- BCR (Belgian Cancer Registry) validation requested: alle hoofdstukken werden ingevuld en de verantwoordelijke voor de registratiefiche (Responsible Specialist) vraagt validatie van de Stichting Kankerregister.

des radiologues experts, sélectionnés par le ‘Belgian Radiological Society’, qui ont reçu les droits d’accès par la Fondation Registre du Cancer. Concrètement, pour pouvoir accéder à cette application ce type d’utilisateur doit :
radioloog-experten, geselecteerd door de ‘Belgian Radiological Society’, die via de Stichting Kankerregister toegangsrechten hebben verkregen Concreet, om toegang te krijgen tot deze toepassing moet deze gebruiker:

La tumorothèque électronique virtuelle « Belgian Virtual tumourbank – BVT », gérée par le Registre du cancer a été développée en 2011.
In 2011 werd de door het Kankerregister beheerde virtuele elektronische tumorbank " Belgian Virtual tumourbank - BVT" ontwikkeld.